Since 1974, R&D expenditures have been fully expensed when incurred partly because R&D activities are claimed to be associated with a high degree of uncertainty in future economic benefits. In this study, we estimate the association between R&D expenditures and capital expenditures (CAPEX) and the variance of future earnings per share and operating income. We show that R&D expenditures lead to higher volatility of future earnings than capital expenditures only in R&D-intensive industries, where industry R&D intensity is measured as the R&D-to-CAPEX ratio. We also find that the stronger association of R&D with uncertainty in future earnings is a recent phenomenon. Finally, we show that in industries that are relatively less dependent on R&D activities, the probability of recovering R&D expenditures is similar to that of capital expenditures. Overall, our results suggest that while some industries engage in a more innovative and uncertain R&D activities, R&D in other industries is less uncertain. These results suggest that the impact of R&D on future performance considerably varies across industries and time periods.
of R&D and its effect on earnings, value and risk considerably varies over time, across companies and in particular across industries.
The purpose of this study is therefore to examine whether the nature of the relation of R&D expenditures and variability of future performance varies across industries and how it evolves over time. Our first hypothesis is that the association between R&D and the variability of future economic benefits varies across industries in a systematic and predictable manner. In particular, we hypothesize that R&D is more associated with uncertainty in future benefits than capital expenditures in industries in which R&D is a crucial driver of profitability. In industries in which capital expenditures are the main driver of profitability and performance we would expect weaker relation between R&D and variability of future benefits.
The second hypothesis advanced here relates to the possibility that a fundamental shift in the way R&D projects are conducted has occurred in recent years. Specifically, the information age revolution, which has witnessed an exponential increase in computing power coupled with the development of efficient and rapid communication channels between the scientific communities, entrepreneurs and companies, has introduced possibilities for innovation that were not available before. A recent article in The Economist 1 suggests, however, that its impact has not been uniform across industries. Fast changing businesses whose success depends on the ability to introduce genuinely new products have embraced the new frontiers by increasing spending on R&D in the hope of finding one big winner. But, according to this article, despite the increase in R&D, genuine innovations are fewer and far between. In other industries the impact of the information age revolution has not been as dramatic since R&D is directed at making relatively small improvements to existing products. In such industries, R&D expenditure ================================================ = 1 "Don't laugh at gilded butterflies," The Economist April 22 nd 2004. in recent years has not grown much and the rate of success has remained relatively unchanged.
Given the differential impact of information technology across industries, we conjecture that in early years the relation between R&D and the variability of future performance was relatively weak and quite similar across industries.
To examine these issues we collect a sample including all industries for which we could obtain at least 1,000 firm-year observations with positive R&D expenditures. This is done to ensure that we focus on industries with long "tradition" of expenditure on R&D. The nine sample industries include traditional ones, such as Rubber & Plastics Products, as well as R&D-intensive ones, such as Computers and Pharmaceuticals.
We define a measure of the relative importance of R&D to a firm's success, which is based on the ratio of annual R&D expenditures to annual capital expenditures (R&D-CAPEX ratio).
Industries that exhibit high R&D-CAPEX ratios are thought to be strongly reliant on R&D (e.g., Pharmaceuticals and Computers). Industries that exhibit low R&D-CAPEX ratios are less R&D dependent (e.g., Metal Machinery and Rubber and Plastics).
We first assess what are the total benefits accruing to an investment of $1 in R&D. We find that the undiscounted stream of benefits exceeds the original investment. This suggests that investments in R&D are generally recoverable in our sample firms. This analysis also enables us to assess the economic amortization rates of the implied R&D capital across the nine industries.
We find that useful life of R&D capital ranges between five and seven years. On this dimension we observe little difference between traditional industries and R&D-intensive industries.
We then find that for industries with high R&D-CAPEX ratios, R&D exhibits greater association with the variability of future benefits than capital expenditures. However, this result is not obtained for industries with low R&D-CAPEX ratios. Incorporating measures of R&D capital from the first analysis we also compare the association between R&D capital and property plant and equipment (PPE) with variability of future performance. The results are similar to the ones for R&D and capital expenditures. That is, R&D capital is more highly associated with variability of future performance than PPE mainly for R&D-intensive firms.
Analyzing the evolution in the R&D-CAPEX ratio we note the beginning of an upward trend in the mid 1980s in R&D-intensive industries, but no discernable trend for other industries.
Accordingly, we split our sample period into two sub-periods: 1972-1985 (early period) and 1986-1999 (late period) . Firms in industries that exhibit high R&D-CAPEX ratios in the later period seem to have significantly increased their investment in R&D relative to capital expenditure over time. In contrast, we do not observe similar pattern in industries that exhibit low R&D-CAPEX ratios in the late period. Furthermore, firms in industries that exhibit high R&D-CAPEX ratios in the later period are also characterized by an increase in the variability of R&D expenditures over time. Firms in industries that exhibit low R&D-CAPEX ratio in the second period seem to have maintained similar variability of R&D over time. Interestingly, the variability of capital expenditures seems to have decreased over time quite uniformly across all industries. Against this background, we find that in the late period R&D expense and R&D capital contribute to future earnings volatility more than capital expenditure and PPE for industries with high R&D-CAPEX, but not so for industries with low R&D-CAPEX ratios.
Moreover, in the earlier period we do not find a systematic relation between R&D and volatility of future performance across the sample's industries.
We also conduct likelihood tests to empirically assess how often investments in R&D and property plant and equipment are recovered by future performance. The likelihood tests reveal that, on average, R&D expenditures are less likely to be recovered than CAPEX. However, this "on-average" result is driven by R&D-intensive industries for which R&D is expected to involve higher risk. In industries that are relatively less R&D-dependent, R&D expenditures are as likely as CAPEX to be recovered.
The results in this study support the claim that a uniform accounting treatment (either expensing or capitalization) of R&D is incompatible with the economics of R&D. Rather, our results support the development of industry-based standards and/or implementation guides for R&D. This is because R&D activity should be analyzed in its specific economic context. Interestingly, our analysis suggests that SFAS 2, which came into power in the early 1970s, is probably most applicable today (though only in certain industries), but was somewhat premature when it was originally conceived.
This study proceeds as follows: Section 2 reviews prior literature. Section 3 describes the sample selection and research design. Section 4 provides descriptive statistics on our total sample and the industries. In Section 5 we provide the results of our analyses. Section 6 contains concluding remarks.
Prior Literature
Much of the research on accounting for R&D has focused on relevance issues, in particular, the value-relevance of R&D outlays (e.g., Dukes et al., 1980; Hirschey and Weygandt 1985; Chan et al., 1990; Wasley and Linsmeier 1992; Sougiannis 1994) . Lev and Sougiannis (1996) take this research one step further and show that unamortized R&D capital, estimated using the association between lagged R&D expenditures and current operating income margin, improves the explanatory power of stock returns. Simulating the R&D discovery process in the pharmaceutical industry, Healy et al. (2002) provide evidence that capitalization using the successful efforts method is more highly associated with firm value or changes in firm value than immediate expensing. These findings support those who claim that R&D expenditures should be capitalized on the balance sheet.
The reliability of R&D expenditures has been virtually neglected by researchers, perhaps due to the lack of a unified definition of reliability and benchmark against which researchers would be able to conduct empirical testing. Kothari et al. (2002) offer a test that relates R&D and capital expenditures to the volatility of future earnings per share. They show that the variability of future earnings per share increases in R&D outlays more than in capital expenditure outlays.
This evidence is consistent with the claim that R&D expenses are less reliable than capital expenditures. The difficulty that arises in reconciling their results with those reported by Lev and Sougiannis (1996) rests with the trade-off between relevance and reliability. The implied conclusion from these two studies is that R&D expenditures are related to future economic benefits; however, this relation may be insufficiently reliable to warrant capitalization.
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Our study contributes to the literature along the following dimensions. First, we perform our analysis on an industry basis allowing identifications of circumstances in which R&D is more or less uncertain than capital expenditures. This analysis may be useful to policy makers in assessing the need for change in accounting for R&D. Second, we take into account in our empirical design possible structural changes that may have resulted from rapid technological developments. Specifically, the emergence of the New Economy has been associated with many firms making unprecedented bets on developing cutting edge products and services. In an earlier period, when the temptation for and the feasibility of such bets was perhaps more subdued, R&D ================================================ = activity may not have been associated with performance uncertainty to the same extent as in recent years (Amir et al., 2003) . Third, we use a wider definition of future benefits, consistent with the broad definition generally used in accounting standards. In addition to EPS, we examine another performance indicator --operating income before R&D, depreciation, amortization and advertising. This measure has the advantage of focusing on core profitability and is also free from the effect of variability in future R&D and capital structure embedded in the variability of future EPS. Finally, in tests that involve comparison of the contribution of R&D capital to variability of future performance relative to property plant and equipment we use industryspecific measures of R&D capital and amortization rates. Furthermore, we adjust future EPS to take account of the capitalization of R&D expenditures.
Sample and Research Design

Sample Selection
Our sample contains data meeting the following requirements. First, it should include only companies with positive R&D spending over the period . Second, it should be possible to calculate measures of future economic benefits over subsequent periods. Third, it should allow us to measure R&D capital, which requires lagged data. Finally, in order to perform a meaningful industry analysis we have restricted the sample to include industries with a minimum of 1,000 firm/year usable observations for which the median R&D expense is at least 2% of the market value of the firm. The final set of industries encompasses:
(1) Miscellaneous Durables: SIC codes 3000-3399 & 3900-3999.
(2) Fabricated Metal and Ex Machinery: SIC codes 3400-3499. The nature of the data selection process ensures that these industries are the most R&D intensive ones in the Compustat population in terms of R&D spending as a proportion of market value of equity. Naturally, a study on the reliability of R&D should focus on R&D-intensive industries, as observations from other industries tend to obscure the underlying relations when they matter the most. Nonetheless, the nine industries used here account for more than 60% of the observations that could be used without this restriction.
Data variables are measured as follows: CAPEX is capital expenditures (Compustat data #128). RDEX is research and development expense (data #46). ADEX is advertising expense (data #45), with a zero reported amount not treated as a missing value. SIZE is the natural log of market value of equity, MVE, which is measured as the product of fiscal year-end closing share price (item #199), and common shares outstanding (item #54). FLEV is a measure of financial leverage and is measured as long-term debt (item #9), plus current portion of long-term debt (item #34), divided by long-term debt plus current portion of long-term debt plus MVE. EPS is earnings per share before extraordinary items and discontinued operations (data #58). OPIN is operating income before depreciation, amortization, advertising and R&D (data #13 + data #45 + data #46).
Annual Cross-Sectional (Fama-Macbeth) Regressions
Our main analysis is based on two regression models similar to those used by Kothari et al. (2002) . In the first model, we estimate the association between the standard deviation of future economic benefits and current investments in R&D deflated by lagged market value of equity (DRDEX), current investments in fixed capital deflated by lagged market value of equity percentile. In addition, similar to Kothari et al. (2002) , we winsorize observations with deflated earnings per share values of less than -1 or greater than 1 at -1 and +1. We also set deflated operating income per share above (below) +2 (-2) to be equal to +2 (-2).
Equation (1) ignores past R&D expenditures and past capital expenditures, which might affect the variation of future economic benefits. We use a second model that includes R&D capital deflated by lagged market value of equity (DRDCAP) and net fixed assets deflated by lagged market value of equity (DPPECAP) as independent variables instead of DRDEX and DCAPEX, respectively. To measure R&D capital (RDCAP it ) we use the method prescribed by Lev and Sougiannis (1996) . In particular, we estimate the useful life and amortization rates for each of our nine industries. Since R&D expenses are capitalized, it is needed to adjust the reported EPS variable, which is measured after full expensing of R&D. Specifically, we remeasure EPS by adding back R&D expense and deducting amortization expense (both adjusted for tax), which is based on industry-specific rates. We then calculate the variability of the adjusted EPS figure. The resulting variable is denoted SDFEPS2.
Where BENEFIT it = {SDFOPIN it , SDFEPS2 it }
We estimate equations (1) and (2) for each year (cross section) and average the regression coefficients over time as in Fama Macbeth (1973) .
Capturing Relative R&D Intensity
Though all nine industries can be described as R&D-intensive, the degree of intensity may vary across industries. Furthermore, the importance of capital expenditures may also vary across industries. The relation between R&D expenses and CAPEX likely captures the strategic importance of R&D. For example, when innovation is the main driver of profitability, one would expect high ratio of R&D to CAPEX. When innovation is directed at small improvements of existing products or services, a low ratio is expected. We would therefore like to distinguish between industries that exhibit relatively high R&D-intensity combined with relatively low capital intensity, and those that exhibit relatively low R&D-intensity combined with relatively high capital intensity. We define a relative intensity measure calculated as:
An industry with a ratio above one is relatively more R&D-intensive. If the ratio is below one, we would say that the industry is relatively more capital-intensive. and are less risky. Similarly, the positive correlation between leverage (FLEV) and the measures of variability is consistent with the argument that both leverage and variance of future economic benefits capture firm risk French 1992, 1993) . Finally, investments in R&D and fixed assets are positively correlated with the standard deviation of future economic benefits, although the degree of correlation differs across the two variability measures.
Descriptive Statistics
( Table 2 about here)
The distribution of R&D and capital intensity has changed over the sample period. Figure ( Table 3 about here)
Results
Estimation of R&D Capital and Amortization Rates
As we discuss above, our regression analysis of Equation 2 requires estimation of R&D capital and amortization rates. We follow the estimation procedure used by Lev and Sougiannis (1996) , on an industry-by-industry basis. Specifically, we estimate the association between R&D expenditures and future operating income and derive R&D's total economic benefits for each industry as well as industry specific R&D amortization rates for the entire sample period, early period (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) and late period (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) .
We estimate the model (using instrumental variables and the Almon lag procedure):
where OPIN is operating income before depreciation, amortization, R&D, and advertising expenses. S is annual sales, RD is R&D expenditures, and AD is advertising expenditures.
The results, which are reported in Table 4 , suggest that the number of significant R&D lags ranges between three and seven, compared with Table 3 in Lev & Sougiannis (1996) which reports lags ranging between four and eight. Also, our estimation procedure yields total economic benefits of R&D ranging between 1.28 and 2.82 for the entire sample period, between 1.46 and 2.69 for the early period, and between 1.49 and 2.83 for the late period. These results are similar to those reported by Lev and Sougiannis (1996) ( Table 4 about here)
The Association between R&D and Variability of Future Benefits
Before we turn to our industry analysis, we first estimate equations (1) and (2) for the entire sample using annual cross-sectional regressions and report mean and standard deviation of the coefficients. All coefficients and t-statistics are adjusted for serial correlation using the Newey-West (1987) procedure. Panel A of Table 5 presents results for the variability of future EPS (SDFEPS1 for equation (1) and SDFEPS2 for equation (2)) as a measure of future economic benefits. At the rightmost column of the panel, we present p-values of the test on the difference between the coefficients on R&D and capital expenditures.
Estimation results of equation (1) for the entire sample-period yield a positive coefficient on R&D expenditures (DRDEX). The average coefficient is significantly larger than zero at the 0.01 level. The average coefficient on capital expenditures (DCAPEX) is 0.031, also significantly different from zero. Also, the average coefficient on DRDEX is larger than the average coefficient on DCAPEX and the difference is significant at the 0.05 level. These results are ================================================ = slightly different that those reported by Kothari et al. (2002) as the coefficient on DRDEX in our study is larger than that reported in their study. There are two possible reasons for these differences. First, our sample period contains data for 1993-1999, years for which R&D is presumably more uncertain and earnings are more volatile. Second, our treatment of replacing missing future earnings is different than the method used by Kothari et al. (2002) . Nonetheless, the main inferences on the differences between the coefficient on R&D and the coefficient on CAPEX are similar across the two studies.
Similar results are obtained with equation (2), where R&D and fixed capital replace R&D and capital expenditures, respectively. Specifically, the average coefficient on R&D capital is positive and significantly different from zero (γ 1 = 0.060, t = 6.76); the coefficient on PPE is significantly different from zero (γ 1 = 0.018, t = 5.97). The difference between the two coefficients is significantly different from zero with a p-value of 0.02.
We also present results for two sub-periods -an early period (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) and a late period (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) . Focusing on the late period 1986-1999, the coefficient on R&D expenditures is 0.136 (t = 8.27) whereas the coefficient on capital expenditures is 0.033 (t = 4.47). The difference between them is significant at the 0.01 level. As for the early period (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) , both coefficients are positive, but the difference between them is not significantly larger than zero at the 0.10 level. The results are similar but stronger when R&D capital and PPE are used instead of R&D expense and capital expenditures, respectively.
To summarize, it is only the later period in which R&D capital contributes more than PPE to the variability of future EPS. Also, the structural change evidenced in these results relates only to R&D and not to capital expenditures as the average coefficient on DCAPEX remains relative constant over time. 0.185). The difference between the two coefficients is significant at the 0.05 level. This is not the case for the early period. However, R&D expenditures contribute significantly more than capital expenditures to the variability of future operating income in the late period (p-value = 0.01).
When equation (2) is estimated for the entire period, the coefficient on R&D capital is larger than the coefficient on fixed capital with a p-value of 0.00. This relation holds in both sub-periods with p-values of 0.08 and 0.00 for the early period and the late period, respectively.
The control variables are generally of the expected sign. The coefficient on advertising expenditures is generally significantly above zero. This result suggests that companies that spend more on advertising have larger volatility of earnings per share and operating income. Also, the coefficients on financial leverage are positive and the coefficients on company size are negative, as expected.
The principal conclusion from this analysis is that R&D contributes more than capital expenditures to the variability of future EPS and future operating income before R&D, depreciation and amortization. However, this result is driven primarily by the late sub-period of 1986-1999. Also, the association between R&D and the variability of future economic benefits has gone through a structural change during the mid-1980. This association has become stronger while the benchmarked association between capital expenditures and variability of future economic benefits has remained relatively unchanged.
( Table 5 about here) Table 6 reports results for our industry analysis, the prime focus of our study. The table is organized along three dimensions. First, the nine industries are sorted by descending order of the R&D-CAPEX ratio. We report the t-statistics for the test that β 1 , the coefficient on R&D expenditure, is equal to β 2 , the coefficient on capital expenditure (Equation 1); and for the test that γ 1 , the coefficient on R&D capital, is equal to γ 2 , the coefficient on PPE capital (Equation 2).
Industry Analysis
The second dimension relates to measures of future economic benefits. We report results for two measures: earnings per share and operating income before R&D, depreciation, amortization and advertising. The third dimension is time. Investment in R&D has become more intense and more volatile over time due to the effects of the "information revolution." Also, relative R&D intensity has increased over time, as shown in Figure 1 . In addition, it may have also changed in different directions in different industries as reported in Table 3 . To test such effects in the context of our study, we report results for an early period (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) and a late period (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) .
To illustrate the structure of the Overall, the results in Table 6 suggest that the effect of R&D activities on the uncertainty of future economic benefits is stronger than that of capital expenditures primarily in industries that are relatively R&D-intensive, as measured by the R&D-CAPEX ratio. Furthermore, this result is driven by recent years as R&D investments have potentially become more uncertain.
This result does not generally hold in industries that are relatively capital-intensive.
( Table 6 about here)
Frequency Analysis
The discussion thus far has focused on the effect of R&D on uncertainty of future economic benefits. However, this discussion has ignored an important feature of accounting recognition: the likelihood of recoverability. A cost could be associated with uncertain future benefits but the likelihood of recoverability could still be very high. Table 4 shows that investment in R&D is recoverable on average. But it is silent on the probability that such investment will generate returns higher than the initial investment. To examine the likelihood of recoverability, we measure the frequency of increases (decreases) in future earnings per share following increases (decreases) in R&D and capital expenditures. Table 7 reports the results for the nine industries, over five periods subsequent to changes in R&D and capital expenditures.
For brevity, we report the results for only earnings per share for the entire sample-period.
Consider first the frequencies associated with R&D expenditures. For industries that are relatively more R&D-intensive these frequencies are 54.65%, 53.46%, 53.08%, 52.44% and 51.32% for one through five periods ahead, respectively. These frequencies are lower (at the 0.05 level) than the corresponding frequencies for industries that are relatively capital-intensive (59.17%, 57.01%, 56.06%, 56.00%, and 54.28%). Next consider the frequencies associated with capital expenditures. These frequencies are similar across the two industry types.
The variable of importance is the difference between the frequencies associated with R&D expenditures with the corresponding frequencies associated with capital expenditures. For industries that are relatively more R&D-intensive these differences are -4.71%, -3.78%, -3.64%, -3.50% and -3.26% for the subsequent five periods, respectively, suggesting that the probability of recoverability is lower for R&D expenditures than for capital expenditures. For industries that are relatively more capital-intensive, these differences are -1.97%, 0.22%, 0.02%, 0.15% and -0.02%, respectively, suggesting that R&D expenditures may not be less recoverable than capital expenditures in these industries. Furthermore, the differences in frequencies between R&D and capital expenditures in R&D intensive industries are all significant at the 0.01 level using a t-test (t-statistics, which are not reported in a table, are -13. 2, -27.8, -27.4, -26.7, and -25.5 for the five subsequent periods, respectively).
The results in Table 7 highlight an important difference between the two types of industries: On average, R&D expenditures are less certain and less likely to be recovered than capital expenditures. However, this is driven by R&D-intensive industries for which R&D is expected to involve higher risk. In industries that are relatively less R&D-dependent, R&D expenditures are as likely as capital expenditures to be recovered.
( Table 7 about here)
Additional Analysis -The Effect of Variability in R&D Expense and CAPEX
The relative effect of R&D and capital expenditures on future performance uncertainty may be influenced by their respective volatility. It is possible that the variability of past and current expenditures is an important determinant of future uncertainty and that it is also correlated with level of these expenditures. To control for this potentially omitted correlated variable problem, we calculate the standard deviation of R&D (SDRDEX) and capital expenditures (SDCAPEX) for each firm over a five-year period that ends in year t-1.
To examine the effect of volatility in R&D and CAPEX on the previous findings, we reestimate equations (1) and (2) after controlling for the volatility of R&D and capital expenditures:
where BENEFIT it = {SDFOPIN it , SDFEPS1 it }.
where BENEFIT it = {SDFOPIN it , SDFEPS2 it }.
We conduct the following tests, expressed as two hypotheses in their null form:
(i) The coefficient on R&D expenditures, DRDEX, is equal to the coefficient on capital expenditures, DCAPEX. That is: β 1 = β 2 .
(ii) The coefficient on R&D volatility, SDRDEX, is equal to the coefficient on CAPEX volatility, SDCAPEX, That is: β 6 = β 7 .
6
The evidence, which is not tabulated here, suggests that including volatility measures in equations (1) and (2) does not change our prior inferences in a fundamental way. That is, the results reported on Table 6 are largely unaffected by the inclusion of volatility measures, as reflected by the results of the first test, β 1 = β 2 . As in Table 6 , the coefficients on R&D expenditures are larger than the coefficients on capital expenditures for relatively R&D-intensive industries but not for relatively capital-intensive ones. However, with uncertainty of EPS being the dependent variable, inclusion of the volatility variables weakens the significance of the tstatistics for the traditional industries in the late period, providing further support to the observation that the impact of R&D on future EPS uncertainty is driven by R&D-intensive firms in recent years.
The second result is that the volatility of R&D is more strongly related to the variability of future EPS than the volatility of capital expenditures in 6 of the 9 industries. This is reflected by the positive and significant t-statistic in our second test, β 6 = β 7 . This result, which is driven by the late period, suggests that more volatile R&D expenditures are associated with more volatile future EPS.
To summarize, inclusion of the volatility variables does not alter the main inference regarding the relative effect of R&D intensity vs. capital expense on uncertainty of future performance. Nonetheless, the volatility of R&D and capital expenditures do influence future performance uncertainty.
================================================ =
Summary and Conclusions
One important aspect of asset recognition relates to the association between an expenditure and future economic benefits. While much of the research on accounting for R&D has focused on the value-relevance of R&D outlays, the uncertainty of R&D expenditures has received little attention. An exception is Kothari et al. (2002) who examine the association between current R&D and capital expenditures and the variability of subsequent earnings per share. They argue that, on average, R&D is significantly more strongly associated with subsequent earnings per share than capital expenditures. This result has implications for standard setting; in particular, it supports the current treatment of full expensing of R&D expenditures under US GAAP.
However, if one is willing to relax the presumption of uniform accounting across different industries, then a large sample study that spans a very large number of industries may obscure the true nature of the association between R&D and volatility of future economic benefits. We therefore study the issue in an industry context and show that the relation between R&D and the volatility of future economic benefits varies over time and by industry in a predictable manner.
In particular, our study shows that R&D contributes more than capital expenditures to the volatility of future economic benefits in industries in which R&D is relatively more intensive than capital but not in industries in which capital is relatively more intensive than R&D.
Specifically, to conduct a meaningful industry analysis we limit our study to nine industries with sufficiently high number of observations. For each industry we calculate a relative intensity measure -R&D expenditures divided by capital expenditures (R&D-CAPEX ratio). Then we show that R&D contributes more than capital expenditures to the variability in future earnings per share only in industries that are relatively more R&D intensive but not in industries that are relatively more capital intensive. In addition, we show that R&D has become more uncertain over time. Finally, we conduct a frequency test aimed at measuring the likelihood of recoverability of R&D and capital expenditures. We find that R&D expenditures are less likely to be recovered only in industries that are relatively R&D-intensive.
Our results have some interesting implications for standard setting and financial statement analysis. First, the results suggest that a uniform accounting rule (either expensing or capitalization) for R&D expenditures may not be justified under classic accounting theory. Our results support an accounting rule that takes into account industry and firm specific circumstances, such as SFAS 86 (computer software development costs) and International Accounting Standard (IAS) 38, Intangible Assets, whereby development costs are expensed or capitalized depending on firm and market specific circumstances. Note: The calculation of R&D capital is based on industry-specific amortization rates presented in Table 4 . As such calculation requires lagged R&D data for a maximum of seven years, the Fama-MacBeth annual coefficients presented in the above figure start from 1979. R&D amortization is based on the industry-specific amortization rate generated by the Almon lag procedure as reported in g. DRDCAP -Research and Development Capital, divided by lagged market value of equity (Item 199 multiplied by item 54). R&D Capital is calculated following the industry-specific amortization rate generated by the Almon lag procedure for the whole sample period as reported in Table 4 . We set values above (below) the 99% (1%) percentile to be equal to the 99% (1%) percentile.
h. DADEX -Advertising Expenditures (Compustat item 45), divided by lagged market value of equity (Item 199 multiplied by item 54). Missing values are set equal to zero. We set values above the 99% percentile to be equal to the 99% percentile.
i. FLEV -Financial Leverage, measured as long-term debt (Compustat item 9) plus current portion of long-term debt (item 34), divided by long-term debt plus current portion of long-term debt plus the market value of equity. We set values above (below) the 99% (1%) percentile to be equal to the 99% (1%) percentile.
j. SIZE -Natural logarithm of market value of equity (Compustat item 199 multiplied by item 54). We set values above (below) the 99% (1%) percentile to be equal to the 99% (1%) percentile. -1972-1985 (1979-1985 for the second equation); late period -1986-1999. 4 . Number of observations represents annual average. 5. All reported t-statistics are adjusted for serial correlation in the estimated coefficients on the standard deviation using the Newey-West (1987) procedure. We allow a maximum of 5 lags for the entire sample, and 2 lags for the early/late period samples. We report p-values of the test that Notes: 1. The table calculates, for each industry, the frequency that an increase (decrease) in R&D or in Capital Expenditures (CAPEX) is followed by an increase (decrease) in earnings per share. We measure frequencies for changes in EPS one through five periods ahead.
